ABANDONED - NO STATEMENT OF USE FILED
no statement of use filed
on 11 Sep 2023
Last Applicant/ Owned by
PO Box 2102, Lenox MA 01240
Lenox
MA
012402347
Serial Number
97233709 filed on 23rd Jan 2022
Registration Number
N/A
Correspondent Address
Yvonne E. Tingleaf
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
BUPARO
Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological,gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations, namely, an analgesic Read More
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological,gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally
Mark Details
Serial Number
No 97233709
Mark Type
No Service/Collective Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 11th Sep 2023 | ABANDONMENT - NO USE STATEMENT FILED |
| 11th Sep 2023 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| 07th Feb 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 13th Dec 2022 | PUBLISHED FOR OPPOSITION |
| 13th Dec 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 23rd Nov 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 07th Nov 2022 | EXAMINERS AMENDMENT -WRITTEN |
| 07th Nov 2022 | EXAMINERS AMENDMENT E-MAILED |
| 07th Nov 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 07th Nov 2022 | EXAMINER'S AMENDMENT ENTERED |